INSIGHTS ON CLINICAL TRIAL DESIGN

• ISPOR Top 10 HEOR Trends: What Are The Key Themes For 2026-27?

  Healthcare decision-making is evolving fast. Discover how AI, RWE, and changing HTA frameworks are influencing pricing, patient engagement, and market access.

• Redefining Vaccine Trial Recruitment

  Modern vaccine trials demand flexible, transparent recruitment workflows. Discover strategies to overcome enrollment delays and build representative, diverse study cohorts.

• How To Improve Patient ID And Retention In Chronic Disease Trials

  Leveraging primary care for chronic disease studies can accelerate patient identification, access to underrepresented populations, and improve retention rates.

• Advancing Dose Escalation Strategies With Bayesian Modeling

  A CRO was engaged to help a biotechnology sponsor develop a novel oncology therapy design and execute a multicenter, open-label Phase 1/2 dose escalation and expansion study in advanced solid tumors.

• Integrating Clinical Operations And Pharmacovigilance for Safer Trials

  5/19/2026

  Learn how integrated planning strengthens decision-making, reduces downstream risk, and supports patient safety while protecting timelines in high-risk studies.

• The Case For Parallel Processing In Clinical Trial Start-Up

  1/26/2026

  Stop letting outdated processes stall your innovation and learn how parallel processing transforms study start-up from a series of hurdles into a synchronized sprint.

• Advancing Clinical Research In 2025: Meeting FDA Standards In DCT

  1/22/2025

  Explore the key components of new FDA guidance on DCTs, including a focus on participant-centric designs and the use of Mobile Research Units (MRUs) to overcome geographic and technological barriers.

• Clinical Trial Support: Point Of Need vs. Traditional Solutions

  7/24/2025

  Examine the limitations of traditional, fixed-location ophthalmic trial sites and how a mobile assessment model can significantly improve patient retention while ensuring high-quality data collection.

• When Your Protocol Includes Ocular Endpoints

  4/6/2026

  Standardizing ocular endpoint execution reduces participant dropout and eliminates data variability. Specialized oversight secures clinical timelines and ensures high-quality, submission-ready data.